Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | AZN | AMGN | GILD | VRTX |
| Company | Verona Pharma Plc ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 58.30 | 67.15 | 277.04 | 104.74 | 492.23 |
| High | 59.72 | 67.81 | 278.33 | 105.75 | 492.23 |
| Low | 58.14 | 67.09 | 268.50 | 104.49 | 485.08 |
| Last | 58.65 | 67.43 | 274.93 | 104.62 | 487.42 |
| Change | +0.35 | +0.38 | -7.71 | -0.26 | +1.53 |
| % Change | +0.59% | +0.57% | -2.73% | -0.25% | +0.31% |
| Volume | 122,791 | 646,742 | 2,094,934 | 1,618,864 | 208,698 |
| 20-Day Average Volume | 1,291,561 | 6,676,042 | 3,532,376 | 10,039,115 | 1,692,294 |
| Previous Close | 58.30 | 67.05 | 282.64 | 104.88 | 485.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.84 | 70.06 | 297.94 | 107.50 | 489.44 |
| 20-Day Raw Stochastic | 56.96% | 43.38% | 14.01% | 45.45% | 58.36% |
| 20-Day Relative Strength | 48.17% | 41.64% | 38.00% | 47.06% | 50.62% |
| Weighted Alpha | +221.41 | -6.94 | -5.23 | +55.48 | +19.19 |
| Today's Opinion | 40% Buy | 72% Sell | 56% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 56% Sell | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 04/10/25 | +4.21% since 04/10/25 | -2.48% since 04/10/25 | +3.79% since 04/10/25 | +2.33% since 04/10/25 |
| Low | 53.69 on 04/11/25 | 64.44 on 04/11/25 | 268.50 on 04/17/25 | 100.76 on 04/11/25 | 468.30 on 04/11/25 |
| High | 59.83 on 04/14/25 | 68.40 on 04/15/25 | 296.17 on 04/15/25 | 107.18 on 04/14/25 | 502.22 on 04/16/25 |
| 1-Month | |||||
| %Chg | -11.88% since 03/17/25 | -12.63% since 03/17/25 | -13.48% since 03/17/25 | -6.25% since 03/17/25 | -5.29% since 03/17/25 |
| Low | 47.20 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 97.32 on 04/09/25 | 448.14 on 04/07/25 |
| High | 67.38 on 03/20/25 | 77.52 on 03/18/25 | 319.31 on 03/18/25 | 114.75 on 04/03/25 | 516.50 on 03/18/25 |
| 3-Month | |||||
| %Chg | +13.04% since 01/17/25 | +1.50% since 01/17/25 | +0.85% since 01/17/25 | +14.59% since 01/17/25 | +15.30% since 01/17/25 |
| Low | 47.20 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 91.84 on 01/22/25 | 423.49 on 01/21/25 |
| High | 70.40 on 03/03/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +69.23% since 10/17/24 | -13.36% since 10/17/24 | -14.60% since 10/17/24 | +20.47% since 10/17/24 | -2.44% since 10/17/24 |
| Low | 31.60 on 11/04/24 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 85.60 on 10/22/24 | 377.85 on 12/19/24 |
| High | 70.40 on 03/03/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,711,806 | 207,936,416 | 151,961,696 | 130,592,688 | 124,771,696 |
| Shares Outstanding, K | 80,820 | 3,101,214 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 42,280,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -173,420,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 36,660,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -33,830,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.16 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 04/29/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.51 | 14.90 | 22.92 | 0.00 |